Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia

NCT04624906 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Waldenstrom Macroglobulinemia

Interventions

DRUG: Acalabrutinib
DRUG: Bendamustine
DRUG: Rituximab

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]